Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

FDC LTD. - 531599 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform that the Company has scheduled a Earnings Call with the Analysts/Investors through Audio Conferencing on Friday, February 11, 2022 at 03:00 p.m. (IST). At the said meeting, the FDC team shall discuss on the quarterly and Nine months ended financial results of the Company as on December 31, 2021.
09-02-2022
Bigul

FDC LTD. - 531599 - Unaudited Financial Results, Both Standalone And Consolidated, For The Quarter And Nine Months Ended December 31, 2021

 This is to inform that pursuant to Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company, at its meeting held on Wednesday, February 09, 2022, has inter alia, approved the following: 1. Unaudited Financial Results, both Standalone and Consolidated, for the quarter and nine months ended December 31, 2021 enclosed herewith. 2. Limited Review Report of the aforesaid Standalone and Consolidated, as issued by the Statutory Auditors of the Company for the quarter and nine months ended December 31, 2021 enclosed herewith.
09-02-2022
Bigul

FDC LTD. - 531599 - The Board Has Decided February 19, 2022 As The Record Date For The Purpose Of Buyback Offer

 We wish to inform you that the Board of Directors at its meeting held on February 09, 2022 has inter-alia approved the proposal to Buyback its own fully paid up Equity Shares of Re. 1/- each ('Equity Shares') from the equity shareholders of the Company as on Record Date, for upto 29,00,000 fully paid up Equity Shares (being 1.72% of the total paid up equity capital of the Company) at a price of Rs.475/- (Rupees Four Hundred and Seventy Five only) per equity share ('Buyback Offer Price') for an aggregate amount not exceeding Rs.137,75,00,000 (Rupees One Hundred Thirty Seven Crores Seventy Five Lakhs Only) ('Offer Size'), (being less than 10% of the Paid Up Capital and free reserves as on March 31, 2021) on a proportionate basis through the "Tender Offer" route. The Board also noted the intention of the Promoter of the Company to participate in the proposed Buyback. Further, the Board has decided February 19, 2022 as the Record Date for the purpose of Buyback Offer.
09-02-2022
Bigul

FDC LTD. - 531599 - Corporate Action-Buy back

 We wish to inform you that the Board of Directors at its meeting held on February 09, 2022 has inter-alia approved the proposal to Buyback its own fully paid up Equity Shares of Re. 1/- each ('Equity Shares') from the equity shareholders of the Company as on Record Date, for upto 29,00,000 fully paid up Equity Shares (being 1.72% of the total paid up equity capital of the Company) at a price of Rs.475/- (Rupees Four Hundred and Seventy Five only) per equity share ('Buyback Offer Price') for an aggregate amount not exceeding Rs.137,75,00,000 (Rupees One Hundred Thirty Seven Crores Seventy Five Lakhs Only) ('Offer Size'), (being less than 10% of the Paid Up Capital and free reserves as on March 31, 2021) on a proportionate basis through the "Tender Offer" route. The Board also noted the intention of the Promoter of the Company to participate in the proposed Buyback. Further, the Board has decided February 19, 2022 as the Record Date for the purpose of Buyback Offer.
09-02-2022
Bigul

FDC LTD. - 531599 - Board Meeting Outcome for Outcome Of Board Meeting Held On February 09, 2022

 1. Unaudited Financial Results, both Standalone and Consolidated, for the quarter and nine months ended December 31, 2021 enclosed herewith. 2. Limited Review Report of the aforesaid Standalone and Consolidated, as issued by the Statutory Auditors of the Company for the quarter and nine months ended December 31, 2021 enclosed herewith. 3. Buyback of Equity Shares:- Inter-alia approved the proposal to Buyback its own fully paid up Equity Shares of Re. 1/- each ('Equity Shares') from the equity shareholders of the Company as on Record Date, for upto 29,00,000 fully paid up Equity Shares (being 1.72% of the total paid up equity capital of the Company) at a price of Rs.475/- (Rupees Four Hundred and Seventy Five only) per equity share ('Buyback Offer Price') for an aggregate amount not exceeding Rs.137,75,00,000 (Rupees One Hundred Thirty Seven Crores Seventy Five Lakhs Only)
09-02-2022

FDC surges 8% as board to consider share buyback proposal

 The company's board will meet on February 9, 2022 to consider the proposal for buyback of equity shares of the company through tender offer route.
07-02-2022
Bigul

FDC LTD. - 531599 - Receipt Of GMP (Good Manufacturing Practice) Certificate From Pics - NPRA (National Pharmaceuticals Regulatory Agency), Malaysia.

 Dear Sir/Madam, This is to inform you that the Company's Oral solid dosage facility located at Phase III/A, Plot No. L-121/B, Salcette, Verna Industrial Estate Verna Goa - 403 722 has received a Good Manufacturing Practice (GMP) certificate and it continues with its approved status from PICs - NPRA (National Pharmaceutical Regulatory Agency), Malaysia. Kindly take the above on record. Thanking you, Yours truly, For FDC LIMITED Sd/- Varsharani Katre Company Secretary & Compliance Officer M No.: FCS-8948
04-02-2022

FDC to consider a proposal for buyback of shares

 FDC Q3 results update: The company will also announce its quarterly results on 9 February.
04-02-2022
Bigul

FDC LTD. - 531599 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results And Limited Review Report Of The Company For The Quarter And Nine Months Ended December 31, 2021

 FDC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2022 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, February 09, 2022 through Video Conferencing ('VC')/Other Audio Visual Means ('OAVM'), to interalia, consider and approve the Unaudited Financial Results and Limited Review Report of the Company for the quarter and nine months ended December 31, 2021. Further, in accordance with Code of Conduct adopted by the Company, SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 and vide our intimation letter dated December 28, 2021, the Trading Window of the Company has been closed for all the Directors and Designated Persons from Saturday, January 01, 2022, till 48 hours after the declaration of Unaudited Financial Results.
31-01-2022
Bigul

FDC LTD. - 531599 - Company Received ANDA Approval For Ofloxacin Otic Solution, 0.3%.

 This is to inform you that, the Company has been granted ANDA approval by United States Food and Drug Administration (U.S. FDA), for Ofloxacin Otic Solution, 0.3%. Kindly take the same on record.
21-01-2022
Next Page
Close

Let's Open Free Demat Account